Market Access : : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / / Giuseppe Galliverti, Nicola Saraceni and Federico Lega.

If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect st...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
TeilnehmendeR:
Place / Publishing House:Milan, Italy : : Milano University Press,, 2023.
Year of Publication:2023
Language:Italian
Physical Description:1 online resource (164 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02916nam a2200337 i 4500
001 993599263004498
005 20230630064726.0
006 m o d
007 cr |||||||||||
008 230630s2023 it o 000 0 ita d
035 |a (CKB)4960000000467607 
035 |a (NjHacI)994960000000467607 
035 |a (EXLCZ)994960000000467607 
040 |a NjHacI  |b eng  |e rda  |c NjHacl 
041 1 |a ita 
050 4 |a HD31  |b .G355 2023 
082 0 4 |a 658  |2 23 
100 1 |a Galliverti, Giuseppe,  |e author. 
245 1 0 |a Market Access :  |b Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /  |c Giuseppe Galliverti, Nicola Saraceni and Federico Lega. 
246 |a Market Access. Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science  
264 1 |a Milan, Italy :  |b Milano University Press,  |c 2023. 
300 |a 1 online resource (164 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Description based on publisher supplied metadata and other sources. 
520 |a If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect storm, it has become a reality at least since the early years of the new century. The world in which access to the market, the introduction of innovation, and consolidation of sales were built around the supervision of regulatory processes and the share of voice towards the prescribers have become much more complex. A context that many define as VUCA (volatile, uncertain, complex, ambiguous). In this book, therefore, both the reasons that prompted Life Science companies to rethink their strategy by dedicating increasing attention to the political and institutional decision-makers of the Regions and the management of healthcare companies, and the internal organization to support and strengthen their "market access" capabilities. Through the different perspectives - academic, consultancy, managerial - of the three authors, the logic that has guided the "change of skin" of Life Science companies is explored, as the functional tools for market access, the different declinations that this activity has had in the sector, future scenarios and further evolutionary prospects, the connection with the other company functions - sales, marketing, medical management, institutional affairs, administration - and many technical aspects which are the heart of the skills and toolbox required of those who want to successfully develop a career right in the field of market access. 
650 0 |a Life sciences. 
650 0 |a Management. 
776 |z 979-1-255-10022-5 
700 1 |a Lega, Federico,  |e author. 
700 1 |a Saraceni, Nicola,  |e author. 
906 |a BOOK 
ADM |b 2023-07-08 12:04:25 Europe/Vienna  |f system  |c marc21  |a 2023-05-13 19:27:32 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345558210004498&Force_direct=true  |Z 5345558210004498  |b Available  |8 5345558210004498